Journal article
Exploring the Therapeutic Potential of C-Type Natriuretic Peptide for Preeclampsia
BR Fato, N De Alwis, S Beard, NK Binder, N Pritchard, TJ Kaitu'U-Lino, KJ Bubb, NJ Hannan
Hypertension | LIPPINCOTT WILLIAMS & WILKINS | Published : 2024
Abstract
BACKGROUND: Preeclampsia is a serious condition of pregnancy, complicated by aberrant maternal vascular dysfunction. CNP (C-type natriuretic peptide) contributes to vascular homeostasis, acting through NPR-B (natriuretic peptide receptor-B) and NPR-C (natriuretic peptide receptor-C). CNP mitigates vascular dysfunction of arteries in nonpregnant cohorts; this study investigates whether CNP can dilate maternal arteries in ex vivo preeclampsia models. METHODS: Human omental arteries were dissected from fat biopsies collected during cesarean section. CNP, NPR-B, and NPR-C mRNA expression was assessed in arteries collected from pregnancies complicated by preeclampsia (n=6) and normotensive contro..
View full abstractGrants
Awarded by Australian Research Council
Funding Acknowledgements
Salary support was received from the Australian Research Council to N.J. Hannan (No. FT210100193) and the National Health and Medical Research Council Fellowships to T.J. Kaitu'u-Lino (No. 1159261). The funders had no role in the study.